Poster Abstracts


[ ]

Linda Swift
FMX CME Program Strategist
(800) 274-2237, ext. 6561

Abstracts should be no more than two pages. Include the specific ICD-9 code in parentheses following any diagnosis mentioned. A suggested format for abstracts is provided here for your convenience. It is not required that this format be followed. View a sample abstract.

Suggested Format


State clearly in one or two sentences what questions you addressed in this study.

Research Design

Describe the basic design. Include any of the following elements that apply to your study:

  • Randomization? Non-randomization?
  • Double-blind? Single-blind? Not blinded?
  • Placebo-controlled?
  • Crossover?
  • Before-after trial?

For studies of screening or diagnostic tests:

  • Criterion standard?
  • Blinded or masked comparison?

For studies of prognosis:

  • Inception cohort?
  • Cohort?

For studies of causation:

  • Randomized?
  • Cohort?
  • Case-control?
  • Survey?

For clinical description:

  • Survey?
  • Patient series?

For studies of economic evaluation:

  • Cost-effectiveness?
  • Analysis?
  • Cost-benefit analysis?


Is it general community, primary care center, referral center, private practice, or institution?


  • Clinical disorder(s)
  • Critical social features
  • Critical demography
  • Number of patients
  • How selected
  • Exclusions
  • Characteristics of matching, if used

For follow-up studies:

  • Duration of follow-up
  • Proportion completing follow-up
  • Who did not follow-up

For intervention studies:

  • Number of patients withdrawn for adverse reactions

Selection Procedure

  • Random sample?
  • Consecutive sample?
  • Volunteer sample?
  • Convenience sample?


Describe essential features, including methods and duration of administration.

Measurements and Main Results

Be precise and concise. Use sensitivity, specificity, and positive predictive and negative predictive values, when appropriate. Give main results of study.


All major conclusions supported by data should be given. Provide clinical application; be conservative and do not overgeneralize. Note if additional study is recommended.

Sample Abstract


To determine whether beta-hemolytic streptococci (BHS) from groups other than A are an important cause of sporadic pharyngitis in children


Cross-sectional, case-referent survey


General pediatric clinic at a military base in Ohio


150 children with symptomatic pharyngitis and 150 controls matched for age and time of presentation over a 20-month study period



Measurements/Main Results

Anaerobic culture technique was used to improve isolation of BHS. Group A BHS was detected significantly more often among the ill children than among the controls (39% vs. 16%, p<0.01). In contrast, non-group A BHS were isolated in similar frequency from the ill and control children (17% vs. 21%). Non-group A BHS from groups B, C, F, and G were each isolated in similar frequency among the ill and control children. The isolation rate of non-group A organisms increased with age among both patients and controls.


Non-group A BHS appeared not to be an important cause of sporadic pharyngitis in this pediatric population.